Can glucosamine and chondroitin help knee pain?
They may help: a review of about 3,800 people found reported pain relief, but the overall evidence remains mixed.
Midi’s article reviews evidence relevant to our [Glucosamine & Chondroitin / MSM]( /health-practices/supplements-botanicals/glucosamine-chondroitin-msm) community. The review combined studies of people with knee osteoarthritis. This is a condition where the cushioning tissue in joints breaks down. Glucosamine and chondroitin occur naturally in that tissue.
People taking the combination reported less pain and stiffness, and better movement. The comparison was with a placebo, a pill without active ingredients. But the researchers said better-quality studies are needed. The article gives no number for how much pain improved. Reported relief is promising, but it is not a firm answer.
The form of glucosamine may also matter. Its sulfate and hydrochloride forms are different and cannot be treated as interchangeable. The article says overall findings are too inconsistent to confirm a benefit. It also reports that the American College of Rheumatology’s 2026 guidelines recommend against these supplements for osteoarthritis.
MSM, a sulfur compound often added to joint supplements, has less human evidence. Most studies have been small and short. Blended products also make it hard to separate MSM’s effects from other ingredients.
For members tracking Joint Pain, useful notes could include pain scores, stiffness, product ingredients, and dates. Comparing those details may make community experiences easier to understand. A change in symptoms alone cannot prove the supplement caused it.
The article also notes that glucosamine may affect blood sugar. Members already tracking Fasting Blood Glucose could include those results when comparing notes. It also flags interactions with warfarin, a blood-thinning medicine, and shellfish-derived ingredients in some products.
What changes—or lack of changes—have you noticed in your symptoms or numbers while using these supplements?


Comments
No comments yet.